ArticleWorld journal of gastroenterology2002
The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.
Article in World journal of gastroenterology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 32 citations in OpenAlex.
- Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.World journal of gastroenterology · 2004Trial
- Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients.World journal of gastroenterology · 2003Trial
- Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review.Nutrients · 2019Review
- Protective effects of alanyl-glutamine supplementation against nelfinavir-induced epithelial impairment in IEC-6 cells and in mouse intestinal mucosa.Cancer biology & therapy · 2012Article
- Effect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-I and IGFBP-3.World journal of gastroenterology · 2009Article
- Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.World journal of gastroenterology · 2009Review
- Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro.Digestive diseases and sciences · 2008Article
- Intestinal mucosal adaptation.World journal of gastroenterology · 2006Review
- Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice.World journal of gastroenterology · 2006Article
- Glutamine supplemented parenteral nutrition prevents intestinal ischemia- reperfusion injury in rats.World journal of gastroenterology · 2004Article
- In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells.World journal of gastroenterology · 2004Article
- Somatropin (Zorbtive): in short bowel syndrome.Drugs · 2004Review
- Changes of biological functions of dipeptide transporter (PepT1) and hormonal regulation in severe scald rats.World journal of gastroenterology · 2003Article
- Gut in diseases: physiological elements and their clinical significance.World journal of gastroenterology · 2003Review
- Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia.World journal of gastroenterology · 2003Article
- Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats.World journal of gastroenterology · 2003Article
- Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.World journal of gastroenterology · 2003Article
- New and emerging therapies for short bowel syndrome in children.Paediatric drugs · 2003Review
- Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli.World journal of gastroenterology · 2002Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the metabolic effects associated with administration of rhGH and/or Gln in parenterally fed, short-bowel rats.
methodsForty SD rats subjected to 75 % intestinal resection and maintained with parenteral nutrition were randomly divided into 4 groups as follows: -rhGH, -Gln; -rhGH, +Gln; +rhGH, -Gln; +rhGH, +Gln. Body weight and nitrogen balance were evaluated daily. After 6 days of PN, rats were killed, various organs were dissected and weighted, the carcasses were used for analysis of body composition. Serum GH and IGF-1 were determined by RIA method.
resultsWeight loss in rats with rhGH (17.4+/-12.8 g) and rhGH+Gln (23.8+/-3.5 g) was significantly less than rats with PN alone (29.6+/-6. 9 g) and rats with Gln-supplemented PN (31.85+/-12.8 g), P<0.05. The accumulated NB in rats with rhGH (1252.9+/-294.3 mg N/d) and rhGH+Gln (1261.7+/-85.5 mg N/d) was significantly greater than those with PN alone (704.8+/-379.0 mg N/d) and with Gln-supplemented PN (856.7+/-284.4 mg N/d), P<0.05. The absolute weight of gastrocnemius muscle in rats with rhGH (2683.9+/-341.6 mg) and rhGH+Gln (2579.1+/-359.5 mg) was greater than those with PN alone (2176.3+/-167.1 mg) and with Gln-supplemented PN (2141.9+/-353.6 mg). Although the absolute weight of remnant small intestine itself was not significantly different in 4 experimental groups, the weight/length of the segments was greater in rats with rhGH and/or Gln (48.7+/-5.5, 52.7+/-4.1 and 67.4+/-5.3 respectively) than those with PN alone(47.8+/-5.0), there were synergistic effects between rhGH and Gln in improvement of the weight/length of remnant small intestine, P<0.05. Analyses of body carcass composition showed that a higher percentage of carcass weight as protein and a lower percentage of carcass weight as fat were occurred in rats with rhGH (20.8+/-4.0,6.0+/-2.6) and rhGH+Gln(21.3+/-2.4,4.4+/-1.5) than those with PN alone (16.4+/-2.4,9.2+/-3.7) and with Gln-supplemented PN (17.8+/-3.0, 6.3+/-2.0), rhGH had significant effects on alteration of body composition, P<0.05. Serum GH and IGF-1 concentration in rats with rhGH(5.221+/-0.8 and 425.1+/-19.2 ng/ml respectively)and rhGH+Gln(5.507+/-1.0 and 461.1+/-49.9 ng/ml respectively) were greater than those with PN alone(3.327+/-1.7 and 325.8+/-29.6 ng/ml respectively) and with Gln-supplemented PN(3.433+/-0.1 and 347.7+/-55.7 ng/ml respectively), P<0.01.
conclusionrhGH significantly improves the anabolism in parenterally fed. short bowel rats, anabolic effect with Gln is less dramatic, there is no synergistic effect between rhGH and Gln in improvement of whole body anabolism. IGF-1 plays an important part in growth-promoting effects of rhGH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.